tiprankstipranks
Verrica Pharmaceuticals (DE:1NE)
FRANKFURT:1NE
Holding DE:1NE?
Track your performance easily

Verrica Pharmaceuticals (1NE) Financial Statements

2 Followers

Verrica Pharmaceuticals Financial Overview

Verrica Pharmaceuticals's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Verrica Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is €-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ -1.78M$ 5.18M$ 3.83M$ 1.99M$ 2.92M
Gross Profit$ -1.78M$ 5.18M$ 3.83M$ 1.65M$ 2.92M
EBIT$ -22.81M$ -14.82M$ -16.87M-$ -24.80M
EBITDA$ -22.43M$ -14.48M$ -16.56M-$ -24.63M
Net Income Common Stockholders$ -20.05M$ -17.19M$ -20.33M$ -24.61M$ -22.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.00M$ 31.90M$ 48.90M$ 69.50M$ 84.30M
Total Assets$ 32.93M$ 52.01M$ 66.31M$ 81.60M$ 97.15M
Total Debt$ 47.11M$ 46.31M$ 46.44M$ 45.51M$ 43.82M
Net Debt$ 24.11M$ 14.41M$ -2.46M$ -23.99M$ -40.48M
Total Liabilities$ 66.98M$ 65.31M$ 64.80M$ 61.83M$ 54.84M
Stockholders Equity$ -34.05M$ -13.30M$ 1.51M$ 19.76M$ 42.30M
Cash Flow-
Free Cash Flow$ -8.57M$ -16.37M$ -19.95M-$ -14.88M
Operating Cash Flow$ -8.56M$ -16.36M$ -19.95M$ -14.51M$ -14.81M
Investing Cash Flow$ -16.00K$ -11.00K-$ -227.00K$ -65.00K
Financing Cash Flow$ -397.00K$ -640.00K$ -661.00K$ -27.00K$ 44.04M
Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History

Verrica Pharmaceuticals Debt to Assets

Verrica Pharmaceuticals Cash Flow

Verrica Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis